BackTable Urology
Ep. 193 Bladder Cancer Innovations: ESMO 2024 Highlights with Dr. Andrea Apolo
Dr. Andrea Apolo
important because we give cis-platinum-based chemotherapy for patients with muscle-invasive disease in the perioperative setting, neoadjuvant and adjuvant. So that's why I was really excited to hear the results of the Niagara. And of course, we had the press release that it was positive. So really excited to see the results of that trial.
0
💬
0
Comments
Log in to comment.
There are no comments yet.